On Invalid Date, Portage Biotech (NASDAQ: PRTG) reported Q4 2023 earnings per share (EPS) of -$1.88, up 327.27% year over year. Total Portage Biotech earnings for the quarter were -$39.38 million. In the same quarter last year, Portage Biotech's earnings per share (EPS) was -$0.44.
As of Q2 2024, Portage Biotech's earnings has grown year over year. Portage Biotech's earnings in the past year totalled -$144.91 million.
What was PRTG's revenue last quarter?
On Invalid Date, Portage Biotech (NASDAQ: PRTG) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Portage Biotech's revenue was $0.00.
What was PRTG's revenue growth in the past year?
As of Q2 2024, Portage Biotech's revenue has grown null year over year. Portage Biotech's revenue in the past year totalled $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.